Status:

COMPLETED

Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome

Lead Sponsor:

University of Chicago

Collaborating Sponsors:

Merck Sharp & Dohme LLC

Conditions:

Allergic Rhinitis

Eligibility:

All Genders

18-55 years

Brief Summary

The purpose of this study is to find out if the bacteria present in the nose or sinuses of people with seasonal allergies changes during their allergy season. Another purpose of this study is to see i...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Males and females between 18 and 55 years of age.
  • History of tree and/or grass allergic rhinitis for at least 2 years (allergic subjects) or no allergy history at all (normal controls).
  • For allergic subjects, a positive skin test to trees and/or grass antigen within prior 12 months. For non-allergic subjects, negative skin tests to common allergens in the Chicago area.
  • Exclusion Criteria
  • Respiratory disease other than allergic rhinitis, allergic conjunctivitis and mild asthma.
  • Use of nasal steroids, antihistamines in the last 4 weeks.
  • Upper respiratory infection, sinusitis less than 2 weeks before screening.
  • Structural nasal abnormalities or nasal polyps on examination, nasal ulcer, frequent nose bleeding, recent nasal surgery or nasal trauma (within 90 days).
  • Participation in other investigational therapy in the last 30 days.
  • Any systemic disorder or medication interfering with the study.
  • Undergoing allergen desensitization therapy.
  • Not willing to give informed consent
  • Inability to understand the nature and requirements of the study, or to comply with the study procedures.
  • Any social or medical condition that, in the opinion of the investigator, would preclude provision of informed consent, make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    February 1 2012

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT01461200

    Start Date

    March 1 2011

    End Date

    February 1 2012

    Last Update

    March 27 2014

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Chicago

    Chicago, Illinois, United States, 60637